Related Experiment Video
Updated: May 19, 2026
07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
[Glaucoma clinical trials in China].
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|September 5, 2012
Summary
Large-scale, randomized controlled glaucoma clinical trials are crucial for developing effective prevention and management guidelines. China needs to address funding and standardization gaps to improve its glaucoma research capabilities.
Area of Science:
- Ophthalmology
- Clinical Research
- Public Health
Background:
- Glaucoma is a leading cause of irreversible blindness globally, affecting approximately 1.95% to 3.60% of China's population.
- Effective glaucoma prevention and management rely on robust scientific evidence from large-scale, multicenter, randomized controlled clinical trials.
- Developing clinical guidelines and improving treatment strategies necessitates well-designed national glaucoma trials.
Discussion:
- China has accumulated experience in conducting glaucoma clinical trials but faces significant challenges.
- Key deficiencies include insufficient funding, lack of standardized operational procedures, and inconsistent quality control.
- Bridging the gap with developed countries requires strategic improvements in trial infrastructure and execution.
Key Insights:
- The importance of high-quality clinical evidence for glaucoma prevention and management is paramount.
- Tailoring clinical trial designs to China's national medical care system is essential for successful implementation.
- International collaboration and adoption of best practices can accelerate progress.
Outlook:
- Enhancing funding mechanisms and establishing unified operational standards are critical next steps.
- Improving the quality and consistency of glaucoma clinical trials will strengthen evidence-based practice.
- Continued focus on domestic and international data synthesis will guide future research and policy.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...